Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

doctorwithpatient.jpg

Early rhythm control boosts AFib outcomes for patients with obesity, diabetes

Researchers expected these conditions to reduce the benefits of early treatment. However, that was not the case.

PCI

Pilot study looks at same-day discharge PCI for acute coronary syndromes

Study shows same-day discharge is feasible for carefully selected, uncomplicated ACS patients. 

Boston Scientific Reliance 4-Front defibrillation leads

Boston Scientific warns that certain defibrillation leads may put patients at risk

The issue, associated with calcification, can make these devices less effective over time. The Heart Rhythm Society shared a detailed analysis of the situation.

Cardiosense CardioTag

FDA clears wearable heart device that captures multiple signals at once

The newly approved device captures electrocardiogram, photoplethysmogram and seismocardiogram signals at the same time. It can also be paired with advanced AI models to monitor patients for specific conditions.

Thumbnail

ICD patients may experience fear, anxiety or depression due to their devices

Some patients feel anxiety due to the risk of being shocked. Others have device recalls and/or cybersecurity threats on their mind.

Cardiac surgeon John Puskas, MD, Emory University, says CCTA will make invasive angiography obsolete very soon.

CCTA could make invasive angiography a thing of the past

John Puskas, MD, thinks coronary CT angiography is on its way to completely transforming patient care. 

Stereotaxis MAGIC SWEEP electrophysiology catheter

FDA clears first robotically guided EP mapping catheter for ablation

Stereotaxis has received FDA clearance for the first mapping catheter of its kind. The company emphasized that this is just the first of many robotically navigated devices it is working to bring to the U.S. market.

pharmaceutical drug approval process

New drug candidate for AFib fails in first-in-human trial—in fact, it made matters worse

Researchers had thought 2-HOBA might reduce the risk of AFib recurrence after catheter ablation procedures. What they found, however, was that treatment with the compound was actually harmful for patients instead of helpful.